Analyst Ratings for Sarepta Therapeutics (SRPT)
SRPT Rating Summary
SRPT Price Target Summary
- Highest: $224.00 (Wedbush)
- Lowest: $80.00 (Cantor Fitzgerald)
- Average: $156.30
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$156.30 (+17.8%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Avg. $ Target:
$156.30 (+17.8%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/14/2024 | Oppenheimer | Hartaj Singh | Upgrade | Outperform (Perform) |
180.00 (N/A) |
131.70 (132.66) |
0.73% | Details |
| 1/31/2024 | BMO Capital | Kostas Biliouris | New Coverage | Outperform (N/A) |
170.00 (N/A) |
120.50 (132.66) |
10.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
